Intravitreal Fluocinolone Acetonide May Decelerate Diabetic Retinal Neurodegeneration

PURPOSE: There is no prevention or treatment for diabetic retinal neurodegeneration (DRN), which is a complication of diabetes that can occur independently of diabetic retinopathy (DR). We hypothesized that an intravitreal fluocinolone acetonide (FAc) implant may affect the rate of DRN when used in...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Stephanie K., Lee, Kyungmoo, Chen, Zhi, Folk, James C., Schmidt-Erfurth, Ursula, Gerendas, Bianca S., Wahle, Andreas, Wykoff, Charles C., Abràmoff, Michael D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2019
Materias:
Retina
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528841/
https://www.ncbi.nlm.nih.gov/pubmed/31100106
http://dx.doi.org/10.1167/iovs.18-24643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6528841/
https://www.ncbi.nlm.nih.gov/pubmed/31100106
http://dx.doi.org/10.1167/iovs.18-24643

Ejemplares similares